Fennec Pharmaceuticals Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 15.1M | 13.8M | 12.5M | 9.7M | 8.8M | 7.9M | 7.0M | 7.3M |
| Cost of Goods Sold | 570K | 1.8M | 660K | 967K | 373K | 669K | 1.4M | 608K |
| Gross Profit | 14.5M | 12.0M | 11.8M | 8.7M | 8.4M | 7.3M | 5.6M | 6.7M |
| R&D Expenses | 49K | 20K | 29K | 107K | 94K | 50K | 97K | 157K |
| Operating Expenses | 14.7M | 14.6M | 12.0M | 11.4M | 9.2M | 8.2M | 10.8M | 11.7M |
| Operating Income | -119K | -2.6M | -201K | -2.7M | -821K | -959K | -5.2M | -5.0M |
| Other Income / Gains | 320K | -2.1M | -437K | -420K | -344K | -661K | -512K | -514K |
| Net Income | 201K | -4.8M | -638K | -3.2M | -1.2M | -2.0M | -5.7M | -5.6M |
| EPS (Diluted) | 0.006 | -0.17 | -0.023 | -0.12 | -0.042 | -0.072 | -0.21 | -0.20 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.962 | 0.872 | 0.947 | 0.90 | 0.957 | 0.916 | 0.805 | 0.916 |
| General And Administrative Expenses | 3.2M | 8.4M | 6.8M | 7.0M | 5.9M | 4.2M | 6.1M | 6.9M |
| Selling And Marketing Expenses | 11.4M | 6.1M | 5.2M | 4.4M | 3.2M | 3.9M | 4.6M | 4.7M |
| Selling General And Administrative Expenses | 14.6M | 14.5M | 12.0M | 11.3M | 9.1M | 8.1M | 10.7M | 11.5M |
| Other Expenses | 0 | 26K | 12K | 0 | 13K | 25K | 21K | 0 |
| Cost And Expenses | 15.2M | 16.4M | 12.7M | 12.4M | 9.6M | 8.9M | 12.2M | 12.3M |
| Interest Income | 339K | 228K | 152K | 174K | 235K | 374K | 516K | 570K |
| Interest Expense | 7K | 308K | 586K | 617K | 603K | 966K | 1.0M | 1.1M |
| Depreciation And Amortization | 26K | 26K | 26K | 25K | 26K | 26K | 25K | 26K |
| Ebitda | 234K | -4.3M | -26K | -2.5M | -547K | -628K | -4.7M | -4.5M |
| Ebitdaratio | 0.015 | -0.316 | -0.002 | -0.262 | -0.063 | -0.079 | -0.672 | -0.617 |
| Operating Income Ratio | -0.008 | -0.187 | -0.016 | -0.283 | -0.094 | -0.121 | -0.749 | -0.694 |
| Income Before Tax | 201K | -4.7M | -638K | -3.2M | -1.2M | -1.6M | -5.7M | -5.6M |
| Income Before Tax Ratio | 0.013 | -0.34 | -0.051 | -0.327 | -0.133 | -0.204 | -0.822 | -0.765 |
| Income Tax Expense | 0 | 106K | 0 | 0 | 0 | 365K | 0 | 0 |
| Net Income Ratio | 0.013 | -0.347 | -0.051 | -0.327 | -0.133 | -0.25 | -0.822 | -0.765 |
| Epsdiluted | 0.006 | -0.17 | -0.023 | -0.12 | -0.042 | -0.057 | -0.21 | -0.20 |
| Weighted Average Shs Out | 34.3M | 31.2M | 27.9M | 27.7M | 27.6M | 27.5M | 27.4M | 27.3M |
| Weighted Average Shs Out Dil | 35.5M | 31.2M | 27.9M | 27.7M | 27.6M | 27.5M | 27.4M | 27.3M |